Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Micra AV and Micra VR leadless pacemakers for bradyarrhythmia management

The Micra™ AV and Micra™ VR leadless pacemakers are implantable, programmable cardiac devices used to monitor and regulate a patient’s heart rate.

Download brochure

Overview

 World's smallest

Model specifications

Parameter

Micra AV2

Micra VR3

Pacing mode

VVI, VVIR, VOO, OVO, VDD, VDI, ODO, OFF

VVI, VVIR, VOO, OVO, OFF

Mass

1.75 g

1.75 g

Volume

0.8 cc

0.8 cc

Electrode spacing

18 mm

18 mm

Battery longevity

8–13 years†2,4

12 years‡5

Accelerometer-based mechanical atrial sensing

Yes

N/A

Accelerometer-based rate response

Yes

Yes

MRI SureScan

1.5T and 3T

1.5T and 3T

CareLink remote monitoring

Yes

Yes

  

Meet our next generation of Micra leadless pacemakers:
Micra™ AV2 and Micra™ VR2

Micra™ AV2 and Micra™ VR2 transcatheter pacing systems for bradyarrhythmia management with abstract particles background
Find a trained Micra physician.

Enter your ZIP code below to find a physician near you who is trained in Micra leadless pacing therapy. 

Medtronic 24-hour support

800-505-4636

Educational resources on Medtronic Academy

Access interactive courses, videos, and educational resources to extend your learning on Micra.

* The single chamber Micra™ transcatheter pacing system is being described herein as Micra™ VR in order to distinguish it from the (VDD) Micra™ AV product. When information in this document relates to both Micra™ AV and VR, “Micra™ transcatheter pacing systems” is used to represent the portfolio of devices.

† Use conditions include:
8 years = 100% VDD pacing, 60 bpm, pacing threshold 1.5 V, impedance 500 Ω, pulse width 0.24 ms.
13 years = 15% VDD pacing, 70 bpm, pacing threshold 1.5 V, impedance 600 Ω, pulse width 0.24 ms.

‡ Use conditions included: median pacing 53.5%, median pacing threshold 0.50 V, median impedance 543 Ω; 89% of patients with > 10-year projected longevity; 99% of patients with > 5-year longevity.5

1. Nippoldt D, Whiting J. Micra™ transcatheter pacing system device volume characterization comparison. November 2014. Medtronic data on file.

2. Medtronic Micra™ AV MC1AVR1 Device Manual. January 2020.

3. Medtronic Micra™ MC1VR01 Clinician Manual. October 2016.

4. Pender J, Whiting J. Micra™ AV Battery Longevity. January 2020. Medtronic data on file.

5. Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra transcatheter pacing study. Heart Rhythm. May 2017;14(5):702–709. doi: 10.1016/j.hrthm.2017.01.035.